Why the study?
Does S-ICD implantation provide efficacy and safety in European paediatric and young adult patients with congenital heart defects?
Does S-ICD implantation provide efficacy and safety in European paediatric and young adult patients with congenital heart defects?
S-ICD is a safe and effective option for pediatric and young adult patients with congenital heart defects, with optimal outcomes seen in those with BMI > 20 and when using newer implantation techniques.
Supports S-ICD consideration in select young congenital heart patients; extends observational data but leaves open need for randomized confirmation.
This multicentre European paediatric registry showed good S-ICD efficacy and safety in young patients. Newer implantation techniques and BMI > 20 showed better outcome.
No takes yet. Share an insight, caveat, or question.
Silvetti et al. (2022) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: